Celgene (CELG) Misses Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Jefferies Cuts Price Target on Celgene (CELG) as FX Weighs on Near-Term
January 29, 2016 9:07 AM ESTJefferies maintained a Buy rating on Celgene (NASDAQ: CELG), and cut the price target to $146.00 (from $149.00), following the company's 4Q earnings report. FX volatility appears to be weighing a bit on near-term performance prospects. CELG noted that the ~$700-800M negative top-line impact... More
